Efficacy and safety of pyrotinib-based regimens in patients with HER2-positive stage III/IV breast cancer: a real-world retrospective study in China. [PDF]
Zhi L, Huang L, Pang X, Wu Q, Lei Y.
europepmc +1 more source
Perceptions of shorter radical cure Plasmodium vivax treatment regimens and their implementation: a qualitative study among stakeholders in Cambodia. [PDF]
Cassidy-Seyoum SA +12 more
europepmc +1 more source
No G6PD A- (G202A) variant detected among <i>Plasmodium falciparum</i>-positive patients in Awka, Southeast Nigeria: a hospital-based study. [PDF]
Ikegbunam M +10 more
europepmc +1 more source
Uncovering the unique characteristics of different groups of 5-HT5AR ligands with reference to their interaction with the target protein. [PDF]
Kordylewski SK +3 more
europepmc +1 more source
A stage IV high-grade serous ovarian cancer patient carrying ERBB2 amplification and ERBB2 overexpression benefits from late-line pyrotinib treatment: A case report. [PDF]
Zhu B, Liu Y, Li J, Yang W.
europepmc +1 more source
Antimalarial Activity of Aqueous Extracts of Nasturtium (Tropaeolum majus L.) and Benzyl Isothiocyanate. [PDF]
Pintão AM, Santos T, Nogueira F.
europepmc +1 more source
Recent Advances in the Treatment of Malaria. [PDF]
Alghamdi JM +3 more
europepmc +1 more source
Susceptibility of Plasmodium falciparum strains to mefloquine in an urban area in Senegal [PDF]
Hatin, I. +4 more
core
Prospective observational study to assess the feasibility and safety of appropriate <i>Plasmodium vivax</i> radical cure with tafenoquine or primaquine after quantitative G6PD testing during pilot implementation in Thailand. [PDF]
Sudathip P +13 more
europepmc +1 more source
A 3-Year-Old Child With Incidental High-Dose Vitamin D Intoxication: A Case Report and Literature Review. [PDF]
Kasiri H, Farzaneh AH, Khosravi N.
europepmc +1 more source

